CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-28 | Bianco James A. Chief Executive Officer | Gift | −150,000 | 2,173,307 | ||
| 2026-02-12 | Tendler Craig Director | Grant or award · Options (Right to Buy) | +156,240 | 156,240 | ||
| 2026-02-12 | Ng George K Director | Grant or award · Options (Right to Buy) | +156,240 | 156,240 | ||
| 2026-02-12 | MANUSO JAMES S J Director | Grant or award · Options (Right to Buy) | +156,240 | 156,240 | ||
| 2026-02-12 | List Alan Director | Grant or award · Options (Right to Buy) | +156,240 | 156,240 | ||
| 2026-02-12 | Hoffman Robert E. Director | Grant or award · Options (Right to Buy) | +156,240 | 156,240 | ||
| 2026-01-06 | Dearborn Dan Chief Financial Officer | Grant or award · Options (Right to Buy) | +273,696 | 273,696 | ||
| 2026-01-06 | Bianco James A. Chief Executive Officer | Grant or award · Options (Right to Buy) | +610,332 | 610,332 | ||
| 2025-12-12 | Dearborn Dan Chief Financial Officer | Grant or award · Options (Right to Buy) | +1,531,367 | 1,531,367 | ||
| 2025-12-12 | Bianco James A. Chief Executive Officer | Grant or award · Options (Right to Buy) | +3,414,891 | 3,414,891 | ||
| 2025-03-10 | Tendler Craig Director | Grant or award · Options (Right to Buy) | +151,883 | 151,883 | ||
| 2025-01-02 | Hoffman Robert E. Director | Grant or award · Options (Right to Buy) | +51,275 | 51,275 | ||
| 2025-01-02 | MANUSO JAMES S J Director | Grant or award · Options (Right to Buy) | +59,590 | 59,590 | ||
| 2025-01-02 | List Alan Director | Grant or award · Options (Right to Buy) | +51,275 | 51,275 | ||
| 2025-01-02 | Ng George K Director | Grant or award · Options (Right to Buy) | +51,275 | 51,275 | ||
| 2024-11-12 | Bianco James A. Chief Executive Officer | Grant or award · Options (Right to Buy) | +1,065,990 | 1,065,990 | ||
| 2024-11-12 | Dearborn Dan Chief Financial Officer | Grant or award · Options (Right to Buy) | +489,848 | 489,848 | ||
| 2024-10-18 | Yamashita Dennis Chief Scientific Officer | Grant or award · Options (Right to Buy) | +196,790 | 196,790 | ||
| 2024-10-18 | Ng George K Director | Grant or award · Options (Right to Buy) | +35,780 | 35,780 | ||
| 2024-10-18 | Ng George K Director | Grant or award · Options (Right to Buy) | +13,553 | 13,553 |
Page 1 of 18 · 357 trades